Poly Medicure expects its Europe business to recover and international revenue to grow 15% in FY27 as the medtech company accelerates development of advanced cardiology and orthopaedic devices to reduce import dependence and expand globally.
Poly Medicure expects its Europe business to recover and international revenue to grow 15% in FY27 as the medtech company accelerates development of advanced cardiology and orthopaedic devices to reduce import dependence and expand globally.